Literature DB >> 15748235

Vessel wall apoptosis and atherosclerotic plaque instability.

M M Kavurma1, R Bhindi, H C Lowe, C Chesterman, L M Khachigian.   

Abstract

Atherosclerotic cardiovascular disease remains the leading cause of death in the industrialized world. Most cardiovascular deaths result from acute coronary syndromes, including unstable angina pectoris and acute myocardial infarction. Coronary syndromes often arise from acute coronary thrombosis, itself commonly a result of disruption or rupture of the fibrous cap of a lipid-laden atherosclerotic plaque. Despite this huge clinical burden of atherosclerotic plaque instability, our understanding of the molecular mechanisms mediating atherosclerotic plaque disruption and rupture, at a cellular level, remains limited. Placed in a clinical context, this review discusses our current understanding of the molecular basis for atherosclerotic plaque instability, with particular emphasis on the process of apoptosis-or programmed cell death-seen increasingly as playing a key role in a number of cell types within the vessel wall.

Entities:  

Mesh:

Year:  2005        PMID: 15748235     DOI: 10.1111/j.1538-7836.2005.01120.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  16 in total

1.  Ischemic heart disease associated with bortezomib treatment combined with dexamethasone in a patient with multiple myeloma.

Authors:  Hiroyuki Takamatsu; Takeshi Yamashita; Takeharu Kotani; Aiko Sawazaki; Hirokazu Okumura; Shinji Nakao
Journal:  Int J Hematol       Date:  2010-05-11       Impact factor: 2.490

2.  Endothelin-1-induced endothelial microvesicles impair endothelial cell function.

Authors:  L Madden Brewster; Vinicius P Garcia; Ma'ayan V Levy; Kelly A Stockelman; Anabel Goulding; Noah M DeSouza; Jared J Greiner; Jamie G Hijmans; Christopher A DeSouza
Journal:  J Appl Physiol (1985)       Date:  2020-04-23

Review 3.  Endothelial cell heterogeneity and atherosclerosis.

Authors:  William C Aird
Journal:  Curr Atheroscler Rep       Date:  2006-01       Impact factor: 5.113

4.  Lactobacillus acidophilus Increases the Anti-apoptotic Micro RNA-21 and Decreases the Pro-inflammatory Micro RNA-155 in the LPS-Treated Human Endothelial Cells.

Authors:  Mehdi Kalani; Hossein Hodjati; Mahdi Sajedi Khanian; Mehrnoosh Doroudchi
Journal:  Probiotics Antimicrob Proteins       Date:  2016-06       Impact factor: 4.609

5.  Effects and mechanisms of indol-2,3-dione on atherosclerosis.

Authors:  Zhantao Liu; Xuying Ren; Zhihong Yang; Yongjuan Zhao; Lixia Ji; Jing Li; Wang Yue
Journal:  Int J Clin Exp Med       Date:  2014-08-15

6.  B-Myb regulates the A(2B) adenosine receptor in vascular smooth muscle cells.

Authors:  Cynthia St Hilaire; Dan Yang; Barbara M Schreiber; Katya Ravid
Journal:  J Cell Biochem       Date:  2008-04-15       Impact factor: 4.429

7.  Poor 1-year outcomes after percutaneous coronary interventions in systemic lupus erythematosus: report from the National Heart, Lung, and Blood Institute Dynamic Registry.

Authors:  Kathleen Maksimowicz-McKinnon; Faith Selzer; Susan Manzi; Kevin E Kip; Suresh R Mulukutla; Oscar C Marroquin; Thomas C Smitherman; Lewis H Kuller; David O Williams; Mary Chester M Wasko
Journal:  Circ Cardiovasc Interv       Date:  2008-12       Impact factor: 6.546

8.  Multiple myeloma and diabetes.

Authors:  Zeinab A Issa; Mira S Zantout; Sami T Azar
Journal:  ISRN Endocrinol       Date:  2011-11-17

9.  Distribution, size, and shape of abdominal aortic calcified deposits and their relationship to mortality in postmenopausal women.

Authors:  Melanie Ganz; Marleen de Bruijne; Erik B Dam; Paola Pettersen; Morten A Karsdal; Claus Christiansen; Mads Nielsen
Journal:  Int J Biomed Imaging       Date:  2012-06-06

10.  6-Shogaol Protects against Oxidized LDL-Induced Endothelial Injruries by Inhibiting Oxidized LDL-Evoked LOX-1 Signaling.

Authors:  Yun Kai Wang; Ya Jun Hong; Yong Hua Yao; Xiao Min Huang; Xue Bo Liu; Chun Yu Zhang; Lei Zhang; Xiaoliang Leon Xu
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-19       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.